Email Updates
Go to Basic Search
Results
Total Results: 784 records
Showing results for "buprenorphine".
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveillance-report-3.xlsxSeptember 30, 2015 - cardiac or pulmonary issues; homeless or on parole; current medication contraindicated with methadone or buprenorphine … ; history of methadone/buprenorphine maintenance; pregnant; liver disease (note: from Neumann 2013) A … Sublingual buprenorphine / naloxone (8/2 to 16/4 mg daily) (10 assigned, 4 f/u) B. … 50 morphine milligram equivalents Exclusion: cancer, hospice, palliative care, and those prescribed buprenorphine
-
Core Measures TCNY AQA eQARR (pdf file)
digital.ahrq.gov/sites/default/files/docs/resource/Mostashari_List_of_Measures_TCNY_AQA_eQARR_Crosswalk_1_30_08_Mostashari.pdfMay 29, 2009 - were screened for alcohol misuse within the past 12 months Providers prescribing Buprenorphine … Number of unique providers who prescribed Buprenorphine within the past 30 days -
digital.ahrq.gov/sites/default/files/docs/emerging-technologies-discussion-summary-041112.pdfMarch 01, 2013 - The program addresses a number of addictions, but primarily focuses on expanding buprenorphine treatment … The ECHO Model was used to recruit providers for training in buprenorphine treatment, to support their … this study have been impressive; in 2005, New Mexico, with 21 providers, ranked 13th in the number of buprenorphine-certified … A survey of buprenorphine prescribers indicated that providers had experienced an overall positive impact
-
psnet.ahrq.gov/periodic-issue/periodic-issue-393June 28, 2023 - with opioid use disorder (OUD) include prescribing medications to treat OUD (naltrexone, naloxone, or buprenorphine … White patients were significantly more likely to receive buprenorphine and less likely to receive high-risk
-
psnet.ahrq.gov/issue/second-victim-casualties-and-how-physician-leaders-can-helpOctober 14, 2016 - mixed-methods analysis of patient safety incidents involving opioid substitution treatment with methadone or buprenorphine
-
www.ahrq.gov/research/findings/studies/index.html?page=75January 01, 2024 - Evidence supports treatment for opioid use disorder (OUD) with buprenorphine in primary care practices … This study aimed to increase the number of rural PCPs providing OUD treatment with buprenorphine. … described the impact of a practice team training on the implementation and delivery of OUD treatment with buprenorphine
-
psnet.ahrq.gov/issue/efficacy-tolerability-and-dose-dependent-effects-opioid-analgesics-low-back-pain-systematicMarch 02, 2011 - mixed-methods analysis of patient safety incidents involving opioid substitution treatment with methadone or buprenorphine … mixed-methods analysis of patient safety incidents involving opioid substitution treatment with methadone or buprenorphine
-
pbrn.ahrq.gov/news/newsletters/e-newsletter/886.htmlOctober 01, 2023 - barriers common to conventional OUD treatment and prioritizes “medication first” through prescribing buprenorphine
-
pcmh.ahrq.gov/news/newsletters/e-newsletter/886.htmlOctober 01, 2023 - barriers common to conventional OUD treatment and prioritizes “medication first” through prescribing buprenorphine
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-229-opioid-treatments-chronic-pain-evidence-summary.pdfApril 01, 2020 - mechanism of action of opioids used (e.g., pure opioid agonists, partial opioid agonists such as buprenorphine … mechanism of action of opioids used (e.g., pure opioid agonists, partial opioid agonists such as buprenorphine … negative urine samples, more days per week of illicit opioid use, and higher risk of relapse vs. buprenorphine … dependence due to prescription opioids for chronic pain found no difference between methadone vs. buprenorphine … Characterizing opioid withdrawal during double- blind buprenorphine detoxification.
-
digital.ahrq.gov/sites/default/files/docs/emerging-technologies-slides-041112.pdfSeptember 01, 2011 - Program • Weekly telehealth clinic since 2006 • Addresses all addictions, but #1 focus is expanding buprenorphine … treatment for opioid addiction • Used ECHO to recruit providers to become trained in use of buprenorphine … Heavily Hispanic Areas 65 Survey of ECHO Bup Prescribes What has been the impact of prescribing buprenorphine
-
www.ahrq.gov/news/newsletter/e-newsletter/705.htmlMarch 01, 2020 - Literature Acute care, prescription opioid use, and overdose following discontinuation of long-term buprenorphine
-
www.ahrq.gov/sites/default/files/2024-02/green-report.pdfJanuary 01, 2024 - not conducted due to data quality concerns. 6 Treatment and harm reduction uptake, defined as buprenorphine … dispensing naloxone and a greater number of naloxone doses dispensed (both p<0.05) had higher volumes of buprenorphine … naloxone experience is more consistent with pharmacy-based studies of nonprescription syringe access and buprenorphine … telling that our analysis indicated greater naloxone provision in pharmacies with higher rates of buprenorphine
-
www.cahps.ahrq.gov/news/newsletters/e-newsletter/index.html?page=2April 05, 2022 - Prescribing, Adverse Outcomes Increase Significantly When Patients Turn 18 February 1, 2022 Buprenorphine
-
www.healthcare411.ahrq.gov/news/newsletters/e-newsletter/index.html?page=2April 05, 2022 - Prescribing, Adverse Outcomes Increase Significantly When Patients Turn 18 February 1, 2022 Buprenorphine
-
www.innovations.ahrq.gov/news/newsletters/e-newsletter/index.html?page=2April 05, 2022 - Prescribing, Adverse Outcomes Increase Significantly When Patients Turn 18 February 1, 2022 Buprenorphine
-
www.monahrq.ahrq.gov/news/newsletters/e-newsletter/index.html?page=2April 05, 2022 - Prescribing, Adverse Outcomes Increase Significantly When Patients Turn 18 February 1, 2022 Buprenorphine
-
www.cpsi.ahrq.gov/news/newsletters/e-newsletter/index.html?page=2April 05, 2022 - Prescribing, Adverse Outcomes Increase Significantly When Patients Turn 18 February 1, 2022 Buprenorphine
-
www.talkingquality.ahrq.gov/news/newsletters/e-newsletter/index.html?page=2April 05, 2022 - Prescribing, Adverse Outcomes Increase Significantly When Patients Turn 18 February 1, 2022 Buprenorphine
-
www.qualitymeasures.ahrq.gov/news/newsletters/e-newsletter/index.html?page=2April 05, 2022 - Prescribing, Adverse Outcomes Increase Significantly When Patients Turn 18 February 1, 2022 Buprenorphine
SHARE:
Search the AHRQ Archive
Information and reports more than 5 years old may be found in the AHRQ Archive site.
Search Within A Specific AHRQ Site
Click to show only results for the selected site.
psnet.ahrq.gov (501)
effectivehealthcare.ahrq.gov (71)
www.ahrq.gov (68)
ce.effectivehealthcare.ahrq.gov (15)
www.uspreventiveservicestaskforce.org (12)
srdr.ahrq.gov (11)
digital.ahrq.gov (9)
pbrn.ahrq.gov (7)
cahps.ahrq.gov (6)
healthcare411.ahrq.gov (6)
www.cpsi.ahrq.gov (6)
ahrqpubs.ahrq.gov (5)
monahrq.ahrq.gov (5)
patientregistry.ahrq.gov (5)
preventiveservices.ahrq.gov (5)
talkingquality.ahrq.gov (5)
teamstepps.ahrq.gov (5)
www.cahps.ahrq.gov (5)
www.healthcare411.ahrq.gov (5)
www.innovations.ahrq.gov (5)
www.monahrq.ahrq.gov (5)
www.qualitymeasures.ahrq.gov (5)
www.talkingquality.ahrq.gov (5)
hcup-us.ahrq.gov (4)
pcmh.ahrq.gov (4)
cds.ahrq.gov (2)
cdsic.ahrq.gov (1)
srdrplus.ahrq.gov (1)
